Yuta Ohgi

610 total citations
11 papers, 511 citations indexed

About

Yuta Ohgi is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Yuta Ohgi has authored 11 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Yuta Ohgi's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Treatment of Major Depression (4 papers) and Stress Responses and Cortisol (3 papers). Yuta Ohgi is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Treatment of Major Depression (4 papers) and Stress Responses and Cortisol (3 papers). Yuta Ohgi collaborates with scholars based in Japan, United States and Sweden. Yuta Ohgi's co-authors include Takashi Futamura, Kenji Hashimoto, Tetsuro Kikuchi, Noriko Yoshimi, Min Ma, Chun Yang, Chao Dong, Jichun Zhang, Wei Yao and Tamaki Ishima and has published in prestigious journals such as Scientific Reports, Molecular Psychiatry and Psychopharmacology.

In The Last Decade

Yuta Ohgi

11 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuta Ohgi Japan 9 271 175 126 125 123 11 511
Stephanie E. Titus Brazil 10 286 1.1× 176 1.0× 88 0.7× 95 0.8× 84 0.7× 10 463
Sawsan Aboul‐Fotouh Egypt 16 234 0.9× 183 1.0× 53 0.4× 160 1.3× 66 0.5× 28 610
Maria Augusta B. dos Santos Brazil 15 325 1.2× 245 1.4× 150 1.2× 103 0.8× 53 0.4× 21 672
Josh Allen Canada 12 260 1.0× 157 0.9× 59 0.5× 157 1.3× 52 0.4× 24 541
Michelle Chandley United States 13 214 0.8× 119 0.7× 53 0.4× 131 1.0× 48 0.4× 17 545
Yi-Chyan Chen Taiwan 15 148 0.5× 93 0.5× 66 0.5× 122 1.0× 78 0.6× 26 560
Kristian Liaury Japan 13 229 0.8× 105 0.6× 43 0.3× 120 1.0× 118 1.0× 22 517
Georg Nikisch Germany 12 130 0.5× 193 1.1× 99 0.8× 88 0.7× 146 1.2× 17 588
Kyle J. Brymer Canada 11 245 0.9× 161 0.9× 47 0.4× 167 1.3× 51 0.4× 16 536
Nuria García‐Marchena Spain 15 165 0.6× 49 0.3× 146 1.2× 95 0.8× 71 0.6× 35 558

Countries citing papers authored by Yuta Ohgi

Since Specialization
Citations

This map shows the geographic impact of Yuta Ohgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuta Ohgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuta Ohgi more than expected).

Fields of papers citing papers by Yuta Ohgi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuta Ohgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuta Ohgi. The network helps show where Yuta Ohgi may publish in the future.

Co-authorship network of co-authors of Yuta Ohgi

This figure shows the co-authorship network connecting the top 25 collaborators of Yuta Ohgi. A scholar is included among the top collaborators of Yuta Ohgi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuta Ohgi. Yuta Ohgi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ohgi, Yuta. (2020). Alcohol dependence and opioid receptor —Pharmacological profile of nalmefene—. Folia Pharmacologica Japonica. 155(3). 145–148. 4 indexed citations
2.
Amada, Naoki, Hitomi Akazawa, Yuta Ohgi, et al.. (2019). Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5‐HT2A receptors in rats. Neuropsychopharmacology Reports. 39(4). 279–288. 19 indexed citations
3.
Tian, Z. Ryan, Kai Zhang, Lijia Chang, et al.. (2019). Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence. Pharmacology Biochemistry and Behavior. 177. 61–68. 8 indexed citations
4.
Ma, Min, Qian Ren, Yūkō Fujita, et al.. (2017). Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine. Psychopharmacology. 234(21). 3165–3173. 7 indexed citations
5.
Ma, Min, Qian Ren, Chun Yang, et al.. (2016). Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation. Psychopharmacology. 234(4). 525–533. 60 indexed citations
6.
Ma, Min, Qian Ren, Chun Yang, et al.. (2016). Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling. Scientific Reports. 6(1). 39209–39209. 51 indexed citations
7.
Yoshimi, Noriko, Takashi Futamura, Sarah E. Bergen, et al.. (2016). Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis. Molecular Psychiatry. 21(11). 1504–1510. 87 indexed citations
8.
Ishima, Tamaki, Takashi Futamura, Yuta Ohgi, et al.. (2015). Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin–dopamine activity modulator: A role for serotonin 5-HT1A and 5-HT2A receptors. European Neuropsychopharmacology. 25(4). 505–511. 29 indexed citations
9.
Sugino, Haruhiko, Akihito Watanabe, Naoki Amada, et al.. (2015). Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success. Clinical Therapeutics. 37(8). 1632–1642. 32 indexed citations
10.
Yoshimi, Noriko, Yūkō Fujita, Yuta Ohgi, et al.. (2014). Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: A role for serotonin 5-HT1A receptors. Pharmacology Biochemistry and Behavior. 124. 245–249. 37 indexed citations
11.
Ohgi, Yuta, Takashi Futamura, Tetsuro Kikuchi, & Kenji Hashimoto. (2012). Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacology Biochemistry and Behavior. 103(4). 853–859. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie E. Titus Breakdown of academic impact, for papers by Sawsan Aboul‐Fotouh Breakdown of academic impact, for papers by Maria Augusta B. dos Santos Breakdown of academic impact, for papers by Josh Allen Breakdown of academic impact, for papers by Michelle Chandley Breakdown of academic impact, for papers by Yi-Chyan Chen Breakdown of academic impact, for papers by Kristian Liaury Breakdown of academic impact, for papers by Georg Nikisch Breakdown of academic impact, for papers by Kyle J. Brymer Breakdown of academic impact, for papers by Nuria García‐Marchena
Rankless by CCL
2026